RxDoctor Payments Data

Daniel Brody, DO

Family Medicine · Richmond Hill, GANPI 1013371731

Payments from drug & device makers

$14,110in general payments, 2019–2025

Across 792 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • Boehringer Ingelheim$582
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$14,090100%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk125$1,894
AbbVie(2 entities)100$1,663
AstraZeneca(2 entities)60$1,239
Lilly USA, LLC73$1,107
Pfizer52$1,018
Boehringer Ingelheim33$582
Otsuka America Pharmaceutical, Inc.28$548
GSK29$459
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$382
Amgen24$381
Lundbeck LLC17$334
Johnson & Johnson17$294
Esperion Therapeutics, Inc.11$257
Novartis12$242
Merck14$228
Cvrx, Inc.2$209
Idorsia Pharmaceuticals US Inc10$190
Sanofi-aventis U.S. LLC13$186
Takeda Pharmaceuticals U.S.A., Inc.9$159
Exact Sciences10$156
Bayer9$151
Avanos Medical1$142
Antares Pharma, Inc.7$140
Dexcom, Inc.7$132
Biohaven Pharmaceuticals, Inc.5$120
Kowa Pharmaceuticals America, Inc.8$113
Daiichi Sankyo Inc.3$111
Bausch Health US, LLC5$94
Phathom Pharmaceuticals, Inc.8$94
Sumitomo Pharma America, Inc.5$92
Gilead1$91
Radius Health, Inc.3$90
Upsher-smith Laboratories LLC5$87
Biohaven Pharmaceutical Holding Company Ltd.4$83
Amarin Pharma, Inc.5$69
Axsome Therapeutics, Inc.3$66
Astellas Pharma US Inc3$61
Mannkind Corporation3$56
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$55
Eisai Inc.4$51
Abiomed2$49
Actelion Pharmaceuticals US, Inc.1$47
Pulmonx Corporation1$45
Currax Pharmaceuticals LLC3$42
Teva Pharmaceuticals USA, Inc.3$40
Abbott2$37
Insulet Corporation2$36
Medtronic2$36
Madrigal Pharmaceuticals2$34
VBI Vaccine (delaware) Inc.2$32
IBSA Pharma Inc.2$25
Ultragenyx Pharmaceutical Inc.1$24
Halozyme Inc1$23
Jazz Pharmaceuticals Inc.1$23
Neos Therapeutics, LP1$20
AMAG Pharmaceuticals, Inc.1$20
Shield Therapeutics Inc1$20
Redhill Biopharma Inc.1$18
Aimmune Therapeutics, Inc.1$17
Inspire Medical Systems, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,110 in reported general payments places this provider in the 95th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$88,022
Medicare patients
149
Services billed
1,457

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide87$118,657
MounjaroTirzepatide36$41,953
JardianceEmpagliflozin32$36,370
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$24,928
WegovySemaglutide19$24,359
EliquisApixaban15$21,612
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog15$14,775
FarxigaDapagliflozin Propanediol13$14,528
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$10,345
VyvanseLisdexamfetamine Dimesylate15$5,189
Levothyroxine Sodium130$1,845
Albuterol Sulfate HfaAlbuterol Sulfate63$1,757
Duloxetine Hcl33$1,699
Rosuvastatin Calcium170$1,690
Atorvastatin Calcium161$1,630

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$1,894$143,017106 claims
Lilly USA, LLCMounjaro$1,107$41,95336 claims
Boehringer IngelheimJardiance$582$36,37032 claims
GSKTrelegy Ellipta$459$24,92828 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,239$24,87329 claims
PfizerEliquis$1,018$21,61215 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$159$5,18915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Richmond Hill

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →